Illumina

Yahoo Finance • yesterday

Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration

Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March 18, Illumina and Labcorp (NYSE:LH) ann... Full story

Yahoo Finance • 4 days ago

3 Reasons to Avoid ILMN and 1 Stock to Buy Instead

In a sliding market, Illumina has defied the odds, trading up to $126.99 per share. Its 31.7% gain since October 2025 has outpaced the S&P 500’s 1.8% drop. This was partly due to its solid quarterly results, and the run-up might have inves... Full story

Yahoo Finance • 14 days ago

1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with... Full story

Yahoo Finance • 17 days ago

Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably involving Tempus AI Inc and Meta Platforms Inc. These trades reflect Ark’s strategic adjustments amidst evolving market conditions and company-specific developments.... Full story

Yahoo Finance • 17 days ago

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 22 days ago

A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

On February 17, 2026, Sessa Capital disclosed a major buy of Sotera Health(NASDAQ:SHC), adding 10,630,381 shares in an estimated $175.80 million trade based on quarterly average pricing. What happened According to a filing with the Secur... Full story

Yahoo Finance • 25 days ago

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Company Logo Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global liquid biopsy product m... Full story

Yahoo Finance • 27 days ago

Illumina Expands Collaboration With Labcorp To Advance Precision Oncology

(RTTNews) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of next-generation sequencing solutions across the healthcare ecosystem. As part o... Full story

Yahoo Finance • last month

Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Illumina (NasdaqGS:ILMN) expanded its Alliance for Genomic Discovery by adding Regeneron Genetic... Full story

Yahoo Finance • last month

Illumina (ILMN) Gaining from Stronger Than Expected Results

Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Patient Opportunity Equity Strategy return... Full story

Yahoo Finance • last month

AI in Biotechnology Market Research and Global Forecast Report 2025-2035: Opportunities Surge Amid Predictive Modeling, Healthcare Breakthroughs and Agricultural, Environmental Advancements

Company Logo Enhanced AI adoption for predictive drug safety analytics, laboratory process automation, and cost-efficient research pipelines are fueling growth. Expansion in biological datasets, cloud infrastructures, and governmental sup... Full story

Yahoo Finance • last month

Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing

In late February 2026, Illumina, Inc. launched its TruPath Genome whole‑genome solution and expanded clinical sequencing services, including supporting Florida State University’s new pediatric rare disease diagnostic lab. Together, these m... Full story

Yahoo Finance • 2 months ago

Personalized Medicine Market Competitive Landscape Report 2025: Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo Personalized Medicine Market Poised for Tremendous Growth by 2033The global personalized medicine market, valued at approximately US$ 585.53 billion in 2026, is projected to soar to nearly US$ 1.00 trillion by 2033. A report... Full story

Yahoo Finance • 2 months ago

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Cancer Diagnostics Market is set to grow from USD 197.7 billion in 2025 to USD 345.57 billion by 2033, driven by a 7.23% CAGR. Factors like rising cancer incidence, technological advancements in diagnostics, and the impor... Full story

Yahoo Finance • 2 months ago

Lung Cancer Diagnostics Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The Lung Cancer Diagnostics Market is set to expand from US$ 21.74 billion in 2025 to US$ 38.00 billion by 2033, growing at a CAGR of 7.23%. Major growth drivers include increased public access facilities, rise in ambulance s... Full story

Yahoo Finance • 2 months ago

Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche

Company Logo The Next-Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, applications in gen... Full story

Yahoo Finance • 2 months ago

Genetic Testing Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Sustainability, Launches, Mergers, Product Innovations, Revenue Insights

Company Logo The genetic testing market is set to reach USD 49.72 billion by 2033, expanding at a CAGR of 9.79% from USD 23.55 billion in 2025. Key growth drivers include oncology, rare disease diagnostics, and prenatal testing, underscor... Full story

Yahoo Finance • 2 months ago

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

An updated edition of the Jan. 6, 2026, article. Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this field has intensified interest among pha... Full story

Yahoo Finance • 2 months ago

Precision Medicine Analysis Report 2026: A $237.28 Billion Market by 2031 - Strategic Pharma-Big-Tech Alliances Speeding Precision Drug Discovery

Dublin, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" report has been added to ResearchAndMarkets.com's offering. The Precision Medicine... Full story

Yahoo Finance • 2 months ago

Could Nvidia Be the Best Way to Play the AI Boom in 2026?

Key Points Nvidia is a tech juggernaut and the most valuable company in the world right now. Despite OpenAI and Alphabet looking to move away from its hardware, Nvidia's chips remain coveted the world over. The company is still growing... Full story